( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57



*Dr. Kedar Athawale


CoVid-19 infection has been main cause of increased number of patients to all the medical colleges including ours for last six months. The reason can be varied like fear in patients to severity of the symptoms. It was observed that around 80 percent of patients reporting to the registration suspected or had the infection. Avoiding the infection spread is the only way to keep it in control as no vaccine is in site as of today. The main task before the medical practitioner is to diagnose the infection as soon as possible, know the severity of it and treat the infection at the earliest. Radiology plays an important role in diagnosing and knowing the severity of the infection. Much of the literature available as of today has focused on chest CT manifestations of COVID-19 (Zhou et al.[1] Chung et al.[2]). In countries like us due to infection control issues related to patient transport to CT centers, the inefficiencies introduced in CT room decontamination, and lack of CT availability, chest radiography will likely be the most commonly utilized modality for identification and follow up of lung abnormalities due to the CoVid-19 infection. The American College of Radiology notes that CT decontamination required after scanning COVID-19 infected patients does disrupt radiological service availability and it suggests that chest radiography may be considered to minimize the risk of cross-infection (American College of Radiology[3]). The objective of my study is to diagnose and evaluate the severity of CoVid-19 patients using Chest radiograph. This is a retrospective study in which 200 patients attending outdoor facility of our hospital were examined. The findings concluded that -  A normal chest radiograph does not exclude covid-19 infection.  There are variety of radiographic patterns in which the infection can manifest. The most common is multifocal peripheral lung changes of ground glass opacity bilaterally.  Abnormal chest radiograph points to severe disease and thus acts as one of the indicator to start more aggressive treatment. RALE {Radiographic Assessment of Lung Edema} score proved to be helpful in knowing the severity of the infection.

Keywords: COVID-19, Chest radiograph, Ground glass opacities, Pneumonia.

[Full Text Article]




    AUGUST Issue has been successfully launched on 1 August 2022.

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 August 2022 Issue has been Published, Kindly check it on

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database